Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.72 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.60 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.60 |
| ▸ | HPRT1 | P00492 | 5/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.52 |
| ▸ | AHCY | P23526 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2928584 | 1.00 | CYP3A4 (0.72) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL9190527 | 1.00 | CYP3A4 (0.72) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL14665386 | 0.91 | CYP3A4 (0.63) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL14665374 | 0.91 | CYP3A4 (0.63) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL29437221 | 0.90 | CYP3A4 (0.73) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL66563 | 0.90 | CYP3A4 (0.73) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL385752 | 0.90 | CYP3A4 (0.73) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL31414425 | 0.88 | CYP3A4 (0.71) | CYP3A4FGFR1SLC22A6HPRT1ADORA2A | |
| SCHEMBL19994970 | 0.87 | CYP3A4 (0.57) | CYP3A4FGFR1SLC22A6ADORA2AADORA1 | |
| SCHEMBL19994967 | 0.87 | CYP3A4 (0.57) | CYP3A4FGFR1SLC22A6ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118530282-A | Improvement of liver-targeting cyclic phosphate prodrug structure | 广州麦克斯药物研究有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-112463529-B | Temperature control method and device of solid-state memory and related components | 苏州浪潮智能科技有限公司 | 2023-01-10 | — | — | CN | claimed |
| EP-2846788-A1 | USE OF COMPOUNDS FOR THE TREATMENT OF PAIN | Akron Molecules AG (AT) | 2015-03-18 | — | — | EP | claimed |
| WO-2013167743-A1 | USE OF COMPOUNDS FOR THE TREATMENT OF PAIN | AKRON MOLECULES GMBH (AT) | 2013-11-14 | — | — | WO | claimed |
| US-7205404-B1 | Phosphorus-containing prodrugs | METABASIS THERAPEUTICS, INC. (US) | 2007-04-17 | — | — | US | claimed |
| EP-1165570-B9 | NOVEL PHOSPHORUS-CONTAINING PRODRUGS | METABASIS THERAPEUTICS INC (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1165570-B1 | NOVEL PHOSPHORUS-CONTAINING PRODRUGS | METABASIS THERAPEUTICS INC (US) | 2006-08-23 | — | — | EP | claimed |
| EP-0533833-B1 | PHOSPHOROUS PRODUGS | GLAZIER ARNOLD (US) | 1995-12-20 | — | — | EP | claimed |
| JP-6206888-A | — | — | None | — | — | JP | disclosed |
| US-12378306-B2 | Anti-fungal VHH antibodies | Biotalys NV (BE) | 2025-08-05 | — | — | US | disclosed |
| WO-2025133390-A1 | ANTI-FUNGAL VHH ANTIBODIES | Biotalys NV (BE) | 2025-06-26 | — | — | WO | disclosed |
| US-20250206811-A1 | ANTI-FUNGAL VHH ANTIBODIES | Biotalys NV (BE) | 2025-06-26 | — | — | US | disclosed |
| EP-4574981-A1 | ANTI-FUNGAL VHH ANTIBODIES | Biotalys NV (BE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025128741-A1 | OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-06-19 | — | — | WO | disclosed |
| US-5352786-A | Di(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-P-to-luenesulfonyloxypropanes, their producing and utilization | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) | 1994-10-04 | — | — | US | disclosed |
| JP-H06206888-A | N-(3-FLUORO-2-PHOSPHONYLMETHOXYPROPYL) DERIVATIVE OF PURINE AND PYRIMIDINE HETEROCYCLIC BASES, ITS PREPARATION AND USE | AKAD VED CESKE REPUBLIKY | 1994-07-26 | — | — | JP | disclosed |
| EP-0540707-A1 | Di(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION. | CESKOSLOVENSKA AKADEMIE VED (CS) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992020692-A1 | DI(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION | GILEAD SCIENCES, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| WO-1992020691-A1 | Di(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION | C^¿ESKOSLOVENSKÁ AKADEMIE VE^¿D (CS) | 1992-11-26 | — | — | WO | disclosed |
| EP-0454427-A1 | Antiretroviral bases | Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (CZ) | 1991-10-30 | — | — | EP | disclosed |